Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne Boire

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Cancer Cell|January 28, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer PatientsJan Remsik, Jessica A Wilcox, N Esther Babady, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Leptomeningeal anti-tumor immunity follows unique signaling principlesJan Remsik, Xinran Tong, Russell Z Kunes, et al.
Neoplasia (New York, N.Y.)|April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cellsSara Haddock, Tyler J Alban, Şevin Turcan, et al.
Immunity|March 23, 2021
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancerMaria Tello-Lafoz, Katja Srpan, Elisa E Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
Trends in Cancer|December 3, 2025
The evolving landscape of brain metastasis: volume IIManuel Valiente, Carey Anders, Adrienne Boire, et al.
Journal of Neuro-Oncology|June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerRachna Malani, Martin Fleisher, Priya Kumthekar, et al.
NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.
Cell Reports|June 30, 2021
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal disseminationVahan Martirosian, Krutika Deshpande, Hao Zhou, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cancer Cell|January 28, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer PatientsJan Remsik, Jessica A Wilcox, N Esther Babady, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Leptomeningeal anti-tumor immunity follows unique signaling principlesJan Remsik, Xinran Tong, Russell Z Kunes, et al.
Neoplasia (New York, N.Y.)|April 10, 2022
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cellsSara Haddock, Tyler J Alban, Şevin Turcan, et al.
Immunity|March 23, 2021
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancerMaria Tello-Lafoz, Katja Srpan, Elisa E Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
Trends in Cancer|December 3, 2025
The evolving landscape of brain metastasis: volume IIManuel Valiente, Carey Anders, Adrienne Boire, et al.
Journal of Neuro-Oncology|June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerRachna Malani, Martin Fleisher, Priya Kumthekar, et al.
NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.
Cell Reports|June 30, 2021
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal disseminationVahan Martirosian, Krutika Deshpande, Hao Zhou, et al.
Pageof 8